Table 1 Comparison of the baseline data between the two groups of patients

Gender, n (male/%)

49 (79.03)

50 (72.46)

0.381

H. Stroke, n (%)

12 (19.35)

11 (15.94)

0.608

CHD, n (%)

7 (11.29)

8 (11.59)

0.956

DM, n (%)

18 (29.03)

32 (46.38)

0.040

Hypertension, n (%)

44 (70.97)

49 (71.01)

0.995

Smoker, n (%)

31 (50.00)

33 (47.83)

0.804

Drinker, n (%)

26 (41.94)

28 (40.58)

0.875

Age, median (IQR)

60.0 ± 10.4

63.2 ± 9.3

0.406

SBP, mmHg ± SD

148 (133–162)

151 (139–167)

0.390

DBP, mmHg ± SD

88 (78–95)

86 (79–96)

0.854

FBG, mmol/L, median (IQR)

5.18 (4.49–6.95)

5.54 (4.67–7.59)

0.178

GH, %, median (IQR)

5.9 (5.6–6.9)

6.1 (5.6–8.0)

0.409

HCY, umol/L, median (IQR)

12.1 (10.5–13.9)

11.9 (10.5–14.5)

0.921

PLT, ×10⁹/L, median (IQR)

229 (199–254)

217 (180–235)

0.402

HGB, g/L, median (IQR)

148 (140–158)

141 (132–153)

0.423

CHL, mmol/L, median (IQR)

4.27 (3.69–5.43)

4.02 (3.33–4.82)

0.332

HDL, mmol/L, median (IQR)

1.09 (0.94–1.26)

1.11 (0.92–1.27)

0.747

LDL, mmol/L, median (IQR)

2.47 (1.89–3.22)

2.21 (1.75–2.86)

0.970

TG, mmol/L, median (IQR)

1.28 (0.98–1.86)

1.30 (0.96–1.55)

0.627

AST U/L, median (IQR)

20.0 (16.0–26.0)

19.0 (16.0–25.0)

0.943

CRE, umol/L, median (IQR)

69.5 (57.0–77.0)

67.0 (55.0–84.0)

0.655

URE, mmol/L, median (IQR)

5.15 (4.34–6.07)

4.70 (4.04–5.74)

0.211

UA, umol/L, median (IQR)

318.1 ± 89.7

311.1 ± 79.7

0.341